Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 15,179.80 +109.67 0.73%
S&P 500 1,639.04 +12.31 0.76%
Nasdaq 3,452.13 +28.58 0.83%
Ticker Volume Price Price Delta
STOXX 50 2,702.69 +35.37 1.33%
FTSE 100 6,330.49 +22.23 0.35%
DAX 8,215.73 +87.77 1.08%
Ticker Volume Price Price Delta
Nikkei 12,989.80 -43.32 -0.33%
Hang Seng 21,072.70 -153.21 -0.72%
S&P/ASX 200 4,800.60 -25.28 -0.52%
  • Exchange: Tokyo
  • Sector: Health Care
  • Industry: Health Care Facilities/Srvcs
  • Sub-Industry: Health Care Services

Shin Nippon Biomedical Laboratories Ltd

+ Add to Watchlist

2395:JP

1,456 JPY 21 1.46%

As of 01:20:37 ET on 06/18/2013.

Company Profile for Shin Nippon Biomedical Laboratories Ltd (2395)

Shin Nippon Biomedical Laboratories Ltd is a contract research organization. The Company provides pre-clinical testing services in the pharmaceutical industry.

Contact Information

Shin Nippon Biomedical Laboratories Ltd

8-1 Akashi-cho
Chuo-Ku
Japan
Phone: 81-99-294-3389
Fax: 81-3-5565-6160

Key Executives for Shin Nippon Biomedical Laboratories Ltd (2395)

Ryoichi NagataPresident/CEOToshihiko SekiExecutive Vice President
Koichiro FukuzakiSenior Managing DirectorKen TakanashiSenior Managing Director
Hidenobu SamejimaManaging DirectorHisao NakajimaDirector
Takeshi YamakawaDirectorSatoshi MatsumotoDirector
Kazumi UchiDirectorMasahiro UtoExecutive Officer
Nobuaki SakashitaExecutive OfficerShunji HarudaExecutive Officer
Hideyuki HiramaExecutive OfficerYojirou OshimaExecutive Officer
Hideshi TsusakiExecutive OfficerTomoaki HondaExecutive Officer
Takefumi GenbaExecutive OfficerRalph LinExecutive Officer
Takayuki SukamotoExecutive OfficerShinji NitandaExecutive Officer

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil